Analysis of inoculation strategies during COVID-19 pandemic with an agent-based simulation approach

dc.contributor.author Oray Kulaç
dc.contributor.author Ayhan Özgür Toy
dc.contributor.author Kamil Erkan Kabak
dc.contributor.author Toy, Ayhan Özgür
dc.contributor.author Kabak, Kamil Erkan
dc.contributor.author Kulaç, Oray
dc.date.accessioned 2025-10-06T17:48:37Z
dc.date.issued 2025
dc.description.abstract Background: The severity of recent Coronavirus (COVID-19) pandemics has revealed the importance of development of inoculation strategies in case of limited vaccine availability. Authorities have implemented inoculation strategies based on perceived risk factors such as age and existence of other chronic health conditions for survivability from the disease. However various other factors can be considered for identifying the preferred inoculation strategies depending on the vaccine availability and disease spread levels. This study explores the effectiveness of inoculating different groups of population in case of various vaccine availabilities and disease spread levels by means of some performance metrics namely: Attack Rate (AR) Death Rate (DR) and Hospitalization Rate (HR). Method: In this study we have implemented a highly detailed Agent-Based Simulation (ABS) model that extends classical SEIR Model by including five more additional states: Asymptomatic (A) Quarantine (Q) Hospitalized (H) Dead (D) and Immune (M) which can be used as a decision support tool to prioritize the groups of the population inoculated. The approach employs the modelling of daily mobility of individuals their interactions and transmission of virus among individuals. The population is heterogeneously clustered according to age family size work status transportation and leisure preferences with 17 different groups in order to find the most appropriate one to inoculate. Three different Disease Spread Levels (DSL) (low mid high) are experimented with four different Vaccine Available Percentages (VAP) (25% 50% 75% and 85%) with a total of 84 scenarios. Results: As the benchmark under the No Vaccine case Attack Rate Hospitalization Rate and Death Rate goes as high as 99.53% 16.96% and 1.38% respectively. Corresponding highest performance metrics (rates) are 72.33% 15.95% and 1.35% for VAP = 25%, 50.25% 9.55% and 0.94% for VAP = 50%, 24.53% 2.62% and 0.25% for VAP = 75%, and 11.51% 0.002% and 0.08% for VAP = 85%. The results of our study shows that the common practice of inoculation based on the age of individual does not yield the best outcome in terms of performance metrics across all DSL and VAP values. The groups containing workers and students that represent highly interactive individuals i.e. Group (9 10) Group (9 11 10‾) and Group (9 10 11 12‾) emerge as a commonly recommended choice for inoculation in the majority of cases. As expected we observe that the higher is the VAP levels the more is the number of alternative inoculation groups. Conclusions: Findings of this study present that: (i) inoculation considerably decreases the number of infected individuals the number of deaths and the number of hospitalized individuals due to the disease (ii) the best inoculation group/groups with respect to performance metrics varies depending on the vaccine availability percentages and disease spread levels (iii) simultaneous implementation of both inoculation and precautions like lock-down social distances and quarantines yields a stronger impact on disease spread and its consequences. © 2025 Elsevier B.V. All rights reserved.
dc.identifier.doi 10.1016/j.compbiomed.2024.109564
dc.identifier.issn 18790534, 00104825
dc.identifier.issn 0010-4825
dc.identifier.scopus 2-s2.0-85213878925
dc.identifier.uri https://www.scopus.com/inward/record.uri?eid=2-s2.0-85213878925&doi=10.1016%2Fj.compbiomed.2024.109564&partnerID=40&md5=61d16c120e8b6f98e18e057c8b8e18b8
dc.identifier.uri https://gcris.yasar.edu.tr/handle/123456789/8031
dc.identifier.uri https://doi.org/10.1016/j.compbiomed.2024.109564
dc.language.iso English
dc.publisher Elsevier Ltd
dc.relation.ispartof Computers in Biology and Medicine
dc.rights info:eu-repo/semantics/closedAccess
dc.source Computers in Biology and Medicine
dc.subject Agent-based Simulation, Covid-19, Inoculation Strategies, Pandemic, Covid-19 Vaccines, Coronavirus, Health Risks, Vaccines, Agent Based Simulation, Coronaviruses, Death Rates, Disease Spread, Inoculation Strategy, Pandemic, Perceived Risk, Performance Metrices, Risk Factors, Simulation Approach, Covid-19, Agent Based Simulation Model, Article, Asymptomatic Coronavirus Disease 2019, Attack Rate, Cloud Computing, Compartment Model, Coronavirus Disease 2019, Data Accuracy, Data Quality, Decision Support System, Employment Status, Experimental Design, Family Size, Hospitalization, Human, Inoculation, Leisure, Mortality Rate, Pandemic, Performance Indicator, Probability, Quarantine, Risk Factor, Simulation, Social Interaction, Social Status, Susceptible Exposed Infectious Recovered Model, Traffic And Transport, Work Environment, Computer Simulation, Epidemiology, Prevention And Control, Severe Acute Respiratory Syndrome Coronavirus 2, Vaccination, Sars-cov-2 Vaccine, Computer Simulation, Covid-19 Vaccines, Hospitalization, Humans, Pandemics, Sars-cov-2, Vaccination
dc.subject Coronavirus, Health risks, Vaccines, Agent based simulation, Coronaviruses, Death rates, Disease spread, Inoculation strategy, Pandemic, Perceived risk, Performance metrices, Risk factors, Simulation approach, COVID-19, agent based simulation model, Article, asymptomatic coronavirus disease 2019, attack rate, cloud computing, compartment model, coronavirus disease 2019, data accuracy, data quality, decision support system, employment status, experimental design, family size, hospitalization, human, inoculation, leisure, mortality rate, pandemic, performance indicator, probability, quarantine, risk factor, simulation, social interaction, social status, susceptible exposed infectious recovered model, traffic and transport, work environment, computer simulation, epidemiology, prevention and control, Severe acute respiratory syndrome coronavirus 2, vaccination, SARS-CoV-2 vaccine, Computer Simulation, COVID-19 Vaccines, Hospitalization, Humans, Pandemics, SARS-CoV-2, Vaccination
dc.subject Agent-Based Simulation
dc.subject COVID-19
dc.subject Pandemic
dc.subject Inoculation Strategies
dc.title Analysis of inoculation strategies during COVID-19 pandemic with an agent-based simulation approach
dc.type Article
dspace.entity.type Publication
gdc.author.scopusid 57821084100
gdc.author.scopusid 24587842500
gdc.author.scopusid 14521673500
gdc.bip.impulseclass C5
gdc.bip.influenceclass C5
gdc.bip.popularityclass C5
gdc.coar.type text::journal::journal article
gdc.collaboration.industrial false
gdc.description.department
gdc.description.departmenttemp [Kulaç O.] Yasar University, Izmir, 35100, Turkey; [Toy A.Ö.] Department of Industrial Engineering, Yasar University, Izmir, 35100, Turkey; [Kabak K.E.] Department of Industrial Engineering, Izmir University of Economics, Izmir, 35330, Turkey
gdc.description.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
gdc.description.startpage 109564
gdc.description.volume 186
gdc.identifier.openalex W4406053691
gdc.identifier.pmid 39754889
gdc.index.type Scopus
gdc.index.type PubMed
gdc.oaire.diamondjournal false
gdc.oaire.impulse 1.0
gdc.oaire.influence 2.4016626E-9
gdc.oaire.isgreen false
gdc.oaire.keywords Hospitalization
gdc.oaire.keywords Adult
gdc.oaire.keywords COVID-19 Vaccines
gdc.oaire.keywords SARS-CoV-2
gdc.oaire.keywords Vaccination
gdc.oaire.keywords Humans
gdc.oaire.keywords COVID-19
gdc.oaire.keywords Computer Simulation
gdc.oaire.keywords Middle Aged
gdc.oaire.keywords Pandemics
gdc.oaire.keywords Models, Biological
gdc.oaire.popularity 3.3094252E-9
gdc.oaire.publicfunded false
gdc.openalex.collaboration National
gdc.openalex.fwci 1.3199
gdc.openalex.normalizedpercentile 0.72
gdc.opencitations.count 0
gdc.plumx.crossrefcites 1
gdc.plumx.mendeley 11
gdc.plumx.scopuscites 2
gdc.scopus.citedcount 2
gdc.virtual.author Toy, Ayhan Özgür
gdc.virtual.author Kulaç, Oray
person.identifier.scopus-author-id Kulaç- Oray (57821084100), Toy- Ayhan Özgür (14521673500), Kabak- Kamil Erkan (24587842500)
publicationvolume.volumeNumber 186
relation.isAuthorOfPublication 40d5f673-8a20-4e1f-b0a3-777528129295
relation.isAuthorOfPublication 059aeb6b-4dae-4d81-8e7d-f75b69e04b9c
relation.isAuthorOfPublication.latestForDiscovery 40d5f673-8a20-4e1f-b0a3-777528129295
relation.isOrgUnitOfPublication ac5ddece-c76d-476d-ab30-e4d3029dee37
relation.isOrgUnitOfPublication.latestForDiscovery ac5ddece-c76d-476d-ab30-e4d3029dee37

Files